AnalystsLuca IssiLuca Issi's Stock Forecasts
AnalystsLuca Issi
Sectors:
Industries:
Analyst Ranking
Bottom 2%
#4794 out of 4868 analysts
Average Return
-15.44%
Win Rate
28%35 out of 124
Risk vs Reward
Poor
Good
Luca Issi's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Uniqure NvQURE | +137.93% | $5.88 | $13.99 | 2024-01-15 - 2025-01-15 | Buy |
Uniqure NvQURE | +106.15% | $7.16 | $14.76 | 2024-11-05 - 2025-04-30 | Buy |
Alnylam Pharmaceuticals IncALNY | +74.46% | $147.00 | $256.45 | 2024-02-15 - 2025-02-14 | Buy |
Meiragtx Holdings PLCMGTX | +68.01% | $4.22 | $7.09 | 2024-08-12 - 2025-04-30 | Buy |
Alnylam Pharmaceuticals IncALNY | +67.35% | $149.69 | $250.51 | 2024-02-19 - 2025-02-19 | Buy |
Luca Issi Analyst Color
Get additional color on Luca Issi's coverage of popular stocks
Luca Issi's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Apellis Pharmaceuticals IncAPLS | 6 | Hold | $21.00 | +9.32% | Maintains | 10 days ago |
Adverum Biotechnologies IncADVM | 7 | Hold | $5.00 | +53.37% | Maintains | 15 days ago |
Ascendis Pharma AASND | 1 | Buy | $205.00 | +20.28% | Initiates Coverage On | 15 days ago |
Lexeo Therapeutics IncLXEO | 5 | Buy | $20.00 | +408.91% | Maintains | a month ago |
Alnylam Pharmaceuticals IncALNY | 26 | Buy | $330.00 | +25.36% | Maintains | a month ago |
Korro Bio IncKRRO | 7 | Buy | $95.00 | +435.21% | Maintains | a month ago |
Sangamo Therapeutics IncSGMO | 6 | Hold | $2.00 | +159.07% | Reiterates | a month ago |
Ocular Therapeutix IncOCUL | 1 | Buy | $17.00 | +104.82% | Initiates Coverage On | a month ago |
Meiragtx Holdings PLCMGTX | 6 | Buy | $13.00 | +83.36% | Maintains | a month ago |
Allogene Therapeutics IncALLO | 7 | Buy | $10.00 | +495.24% | Reiterates | 2 months ago |
Verve Therapeutics IncVERV | 7 | Buy | $15.00 | +164.55% | Maintains | 2 months ago |
4d Molecular Therapeutics IncFDMT | 7 | Buy | $35.00 | +938.58% | Maintains | 2 months ago |
Beam Therapeutics IncBEAM | 7 | Hold | $26.00 | +30.46% | Maintains | 2 months ago |
Ionis Pharmaceuticals IncIONS | 8 | Buy | $70.00 | +127.94% | Reiterates | 2 months ago |
Biomarin Pharmaceutical IncBMRN | 12 | Hold | $70.00 | +9.91% | Reiterates | 2 months ago |
Moderna IncMRNA | 13 | Hold | $40.00 | +40.15% | Reiterates | 2 months ago |
Crispr Therapeutics AgCRSP | 12 | Hold | $48.00 | +24.13% | Maintains | 3 months ago |
Arrowhead Pharmaceuticals IncARWR | 8 | Buy | $42.00 | +202.38% | Reiterates | 3 months ago |
Uniqure NvQURE | 6 | Buy | $24.00 | +62.60% | Reiterates | 3 months ago |
Schlumberger LimitedSLB | 1 | Buy | $57.00 | +71.43% | Reiterates | 3 months ago |
Regenxbio IncRGNX | 8 | Buy | $30.00 | +212.17% | Reiterates | 3 months ago |
Avidity Biosciences IncRNA | 2 | Buy | $67.00 | +105.21% | Reiterates | 3 months ago |
Dyne Therapeutics IncDYN | 2 | Buy | $45.00 | +281.68% | Reiterates | 4 months ago |
Editas Medicine IncEDIT | 8 | Hold | $4.00 | +142.42% | Maintains | 5 months ago |
Bluebird Bio IncBLUE | 4 | Hold | $80.00 | +1,860.78% | Reiterates | 6 months ago |
Ultragenyx Pharmaceutical IncRARE | 3 | Buy | $77.00 | +97.54% | Reiterates | 6 months ago |
Wave Life Sciences LtdWVE | 5 | Hold | $15.00 | +94.30% | Maintains | 6 months ago |
Intellia Therapeutics IncNTLA | 4 | Buy | $54.00 | +508.79% | Reiterates | 7 months ago |
Caribou Biosciences IncCRBU | 5 | Buy | $14.00 | +1,545.12% | Reiterates | 9 months ago |
Lenz Therapeutics IncLENZ | 3 | Hold | $3.00 | N/A | Maintains | 2 years ago |
Q32 Bio IncQTTB | 3 | Hold | $54.00 | N/A | Maintains | 2 years ago |
Dicerna Pharmaceuticals IncDRNA | 2 | Hold | $38.25 | N/A | Downgrades | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.